Publications found:
36,694
Sort by:
Bronchopulmonary Dysplasia - Pipeline Insight, 2020
US$ 1,250.00
... clients within 48 Hours 'Bronchopulmonary Dysplasia - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Bronchopulmonary Dysplasia development. The report provides ...
January 2020
120 pages
Candidiasis - Pipeline Insight, 2020
US$ 1,500.00
... clients within 72 Hours 'Candidiasis - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Candidiasis development. The report provides detailed ...
January 2020
60 pages
Cataract - Pipeline Insight, 2020
US$ 1,250.00
... clients within 48 Hours 'Cataract - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Cataract development. The report provides detailed ...
January 2020
60 pages
Chemotherapy Induced Anemia - Pipeline Insight, 2020
US$ 1,250.00
... and chemical information Provides pipeline assessment by monotherapy and combination therapy products, stage of development, route of administration, and molecule type for Chemotherapy Induced Anemia The report also ...
January 2020
60 pages
Cholera - Pipeline Insight, 2020
US$ 1,250.00
... clients within 48 Hours 'Cholera - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Cholera development. The report provides detailed ...
January 2020
60 pages
Choroidal Neovascularization - Pipeline Insight, 2020
US$ 1,250.00
... clients within 48 Hours 'Choroidal Neovascularization - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Choroidal Neovascularization development. The report provides ...
January 2020
60 pages
Chronic Back Pain - Pipeline Insight, 2020
US$ 1,250.00
... and chemical information Provides pipeline assessment by monotherapy and combination therapy products, stage of development, route of administration, and molecule type for Chronic Back Pain The report also ...
January 2020
60 pages
Chronic Plaque Psoriasis - Pipeline Insight, 2020
US$ 1,500.00
... and chemical information Provides pipeline assessment by monotherapy and combination therapy products, stage of development, route of administration, and molecule type for Chronic Plaque Psoriasis The report also ...
January 2020
60 pages
Chronic Stable Angina - Pipeline Insight, 2020
US$ 1,250.00
... and chemical information Provides pipeline assessment by monotherapy and combination therapy products, stage of development, route of administration, and molecule type for Chronic Stable Angina The report also ...
January 2020
60 pages
Cirrhosis - Pipeline Insight, 2020
US$ 1,250.00
... clients within 48 Hours 'Cirrhosis - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Cirrhosis development. The report provides detailed ...
January 2020
60 pages
Cluster Headache Syndrome - Pipeline Insight, 2020
US$ 1,250.00
... and chemical information Provides pipeline assessment by monotherapy and combination therapy products, stage of development, route of administration, and molecule type for Cluster Headache Syndrome The report also ...
January 2020
60 pages
Community Acquired Pneumonia - Pipeline Insight, 2020
US$ 1,250.00
... and chemical information Provides pipeline assessment by monotherapy and combination therapy products, stage of development, route of administration, and molecule type for Community Acquired Pneumonia The report also ...
January 2020
60 pages
Condyloma - Pipeline Insight, 2020
US$ 1,250.00
... clients within 48 Hours 'Condyloma - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Condyloma development. The report provides detailed ...
January 2020
60 pages
Congenital Heart Disease - Pipeline Insight, 2020
US$ 1,500.00
... and chemical information Provides pipeline assessment by monotherapy and combination therapy products, stage of development, route of administration, and molecule type for Congenital Heart Disease The report also ...
January 2020
60 pages
Constipation - Pipeline Insight, 2020
US$ 2,000.00
... clients within 5 Days 'Constipation - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Constipation development. The report provides detailed ...
January 2020
60 pages
Contact Dermatitis - Pipeline Insight, 2020
US$ 1,250.00
... clients within 48 Hours 'Contact Dermatitis - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Contact Dermatitis development. The report provides ...
January 2020
90 pages
Contraceptives - Pipeline Insight, 2020
US$ 1,250.00
... clients within 48 Hours 'Contraceptives - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Contraceptives development. The report provides detailed ...
January 2020
90 pages
Corneal Graft Rejection - Pipeline Insight, 2020
US$ 1,250.00
... and chemical information Provides pipeline assessment by monotherapy and combination therapy products, stage of development, route of administration, and molecule type for Corneal Graft Rejection The report also ...
January 2020
60 pages
Coronary Artery Disease (CAD) - Pipeline Insight, 2020
US$ 2,000.00
... and chemical information Provides pipeline assessment by monotherapy and combination therapy products, stage of development, route of administration, and molecule type for Coronary Artery Disease (CAD) The report also ...
January 2020
90 pages
Cystitis - Pipeline Insight, 2020
US$ 1,250.00
... clients within 48 Hours 'Cystitis - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Cystitis development. The report provides detailed ...
January 2020
60 pages
Deep Vein Thrombosis (DVT) - Pipeline Insight, 2020
US$ 1,250.00
... and chemical information Provides pipeline assessment by monotherapy and combination therapy products, stage of development, route of administration, and molecule type for Deep Vein Thrombosis (DVT) The report also ...
January 2020
60 pages
Degenerative Disc Disease - Pipeline Insight, 2020
US$ 1,250.00
... and chemical information Provides pipeline assessment by monotherapy and combination therapy products, stage of development, route of administration, and molecule type for Degenerative Disc Disease The report also ...
January 2020
60 pages
Dementia Associated With Alzheimer's Disease - Pipeline Insight, 2020
US$ 1,250.00
... and chemical information Provides pipeline assessment by monotherapy and combination therapy products, stage of development, route of administration, and molecule type for Dementia Associated With Alzheimer's Disease The report also ...
January 2020
60 pages
Dengue - Pipeline Insight, 2020
US$ 1,500.00
... clients within 72 Hours 'Dengue - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Dengue development. The report provides detailed ...
January 2020
60 pages
Diabetic Nephropathy - Pipeline Insight, 2020
US$ 2,000.00
... clients within 5 Days 'Diabetic Nephropathy - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Diabetic Nephropathy development. The report provides ...
January 2020
60 pages
Diabetic Neuropathic Pain - Pipeline Insight, 2020
US$ 1,500.00
... and chemical information Provides pipeline assessment by monotherapy and combination therapy products, stage of development, route of administration, and molecule type for Diabetic Neuropathic Pain The report also ...
January 2020
60 pages
Diabetic Peripheral Neuropathy - Pipeline Insight, 2020
US$ 1,250.00
... and chemical information Provides pipeline assessment by monotherapy and combination therapy products, stage of development, route of administration, and molecule type for Diabetic Peripheral Neuropathy The report also ...
January 2020
60 pages
Diarrhea - Pipeline Insight, 2020
US$ 2,000.00
... clients within 5 Days 'Diarrhea - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Diarrhea development. The report provides detailed ...
January 2020
60 pages
Diphtheria - Pipeline Insight, 2020
US$ 1,250.00
... clients within 48 Hours 'Diphtheria - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Diphtheria development. The report provides detailed ...
January 2020
60 pages
Duodenal Ulcer - Pipeline Insight, 2020
US$ 1,250.00
... clients within 48 Hours 'Duodenal Ulcer - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Duodenal Ulcer development. The report provides ...
January 2020
60 pages
Dyskinesia - Pipeline Insight, 2020
US$ 1,500.00
... clients within 72 Hours 'Dyskinesia - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Dyskinesia development. The report provides detailed ...
January 2020
60 pages
Dyspepsia - Pipeline Insight, 2020
US$ 1,250.00
... clients within 48 Hours 'Dyspepsia - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Dyspepsia development. The report provides detailed ...
January 2020
120 pages
Emesis (Vomiting) - Pipeline Insight, 2020
US$ 1,250.00
... clients within 48 Hours 'Emesis (Vomiting) - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Emesis (Vomiting) development. The report provides ...
January 2020
120 pages
Encephalopathy - Pipeline Insight, 2020
US$ 1,250.00
... clients within 48 Hours 'Encephalopathy - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Encephalopathy development. The report provides detailed ...
January 2020
90 pages
Eosinophilic Esophagitis - Pipeline Insight, 2020
US$ 1,250.00
... clients within 48 Hours 'Eosinophilic Esophagitis - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Eosinophilic Esophagitis development. The report provides ...
January 2020
60 pages
Epithelial Ovarian Cancer - Pipeline Insight, 2020
US$ 2,000.00
... and chemical information Provides pipeline assessment by monotherapy and combination therapy products, stage of development, route of administration, and molecule type for Epithelial Ovarian Cancer The report also ...
January 2020
60 pages
Erectile Dysfunction - Pipeline Insight, 2020
US$ 1,500.00
... clients within 72 Hours 'Erectile Dysfunction - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Erectile Dysfunction development. The report provides ...
January 2020
60 pages
Fabry Disease - Pipeline Insight, 2020
US$ 1,500.00
... clients within 72 Hours 'Fabry Disease - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Fabry Disease development. The report provides ...
January 2020
60 pages
Fatigue - Pipeline Insight, 2020
US$ 1,250.00
... clients within 48 Hours 'Fatigue - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Fatigue development. The report provides detailed ...
January 2020
60 pages
Febrile Neutropenia - Pipeline Insight, 2020
US$ 1,250.00
... clients within 48 Hours 'Febrile Neutropenia - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Febrile Neutropenia development. The report provides ...
January 2020
60 pages
Fecal Incontinence - Pipeline Insight, 2020
US$ 1,250.00
... clients within 48 Hours 'Fecal Incontinence - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Fecal Incontinence development. The report provides ...
January 2020
60 pages
Friedreich Ataxia - Pipeline Insight, 2020
US$ 1,250.00
... clients within 48 Hours 'Friedreich Ataxia - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Friedreich Ataxia development. The report provides ...
January 2020
60 pages
Gastric Ulcers - Pipeline Insight, 2020
US$ 1,250.00
... clients within 48 Hours 'Gastric Ulcers - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Gastric Ulcers development. The report provides ...
January 2020
120 pages
Gastritis - Pipeline Insight, 2020
US$ 1,250.00
... clients within 48 Hours 'Gastritis - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Gastritis development. The report provides detailed ...
January 2020
60 pages
